Merit Medical Systems, Inc.
NASDAQ Global SelectCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- Martha Goldberg Aronson
- Full Time Employees
- 7,500
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- Address
- 1600 West Merit Parkway South Jordan UT United States of America 84095
- IPO Date
- May 14, 1990
- CIK
- 0000856982
- Website
- merit.com
- Similar Companies
- Business
- Merit Medical Systems, Inc. is a leading worldwide designer, developer, manufacturer, and marketer of proprietary disposable medical devices used in interventional, diagnostic, and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care, and endoscopy. Founded in 1987 and headquartered in South Jordan, Utah, the company operates in two primary segments, Cardiovascular and Endoscopy, offering a broad portfolio of products including micropuncture kits, angiographic needles, sheaths, guidewires, safety devices, inflation devices for angioplasty and stent placement, diagnostic and therapeutic catheters, thrombolytic catheters, fluid dispensing systems, angiography accessories, hemostatic solutions, and procedural kits for peripheral intervention, spine, and oncology applications; it serves hospitals, physicians, and clinicians globally with approximately 7,000 employees and manufacturing facilities worldwide. In May 2025, Merit acquired Biolife Delaware, L.L.C. for approximately $120 million in cash and assumed liabilities, adding the patented StatSeal and WoundSeal hemostatic products that address a $350 million global market opportunity and are projected to contribute $18 million in annual revenue starting in fiscal 2026; earlier transactions include the November 2024 acquisition of assets from Cook Medical Holdings LLC and the July 2024 acquisition of EndoGastric Solutions, Inc., alongside a signed asset purchase agreement in October 2025 for the C2 CryoBalloon from PENTAX Medical to expand its gastroenterology portfolio.
Merit Medical Eyes Next Growth Plan as Margins, Portfolio Review Take Center Stage
Merit Medical Systems Eyes New Long-Range Plan as Growth, Margins Gain Momentum
Merit Medical Systems, Inc. (MMSI) Presents at Bank of America SMID Cap Virtual Conference Transcript
COO vs. MMSI: Which Stock Should Value Investors Buy Now?
Merit Medical to Participate in Upcoming Investors Conferences in August
MMSI Q2 Earnings & Revenues Beat Estimates, '26 Guidance Raised
These Analysts Increase Their Forecasts On Merit Medical Systems After Strong Q2 Results
Merit Medical Systems, Inc. (MMSI) Q2 2026 Earnings Call Transcript
Merit Medical (MMSI) Surpasses Q2 Earnings and Revenue Estimates
Merit Medical (MMSI) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
Merit Medical Reports Second Quarter 2026 Results And Updates Full-Year 2026 Guidance
Watch These 4 Medical Product Stocks for Q2 Earnings: Beat or Miss?
Allspring Global Investments Holdings LLC Sells 32,413 Shares of Merit Medical Systems, Inc. $MMSI
MMSI vs. WST: Which Stock Should Value Investors Buy Now?
Here's Why Merit Medical (MMSI) is a Strong Growth Stock
Here's Why Merit Medical (MMSI) is a Strong Value Stock
Here's Why You Should Add Merit Medical Stock to Your Portfolio Now
Merit Medical Systems to Announce Second Quarter 2026 Results on July 30, 2026
MMSI or WST: Which Is the Better Value Stock Right Now?
Why Merit Medical (MMSI) is a Top Value Stock for the Long-Term